SBI Mutual Fund acquires additional shares of Alkem Labs for Rs 300 crore Ruchika Sharma24 Feb 2025 3:25 PM ISTNew Delhi: SBI Mutual Fund has acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories for Rs 300 crore...
Senores Pharma buys USFDA approved ANDA for COPD drug Ruchika Sharma24 Feb 2025 1:30 PM ISTAhmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has signed an agreement to...
Dr Gavin Screaton to join Board of GSK as Non-Executive Director Ruchika Sharma24 Feb 2025 12:48 PM ISTOn appointment, Dr Screaton will become a member of the GSK Board Science Committee and the Corporate Responsibility Committee.
Syngene International gets 5 USFDA observations for Bengaluru facilities Ruchika Sharma24 Feb 2025 11:30 AM ISTBengaluru: Syngene International has announced that the U.S. Food and Drugs Administration (USFDA) has concluded the inspection with five...
Dr. Rajeev Singh Raghuwanshi Reappointed as Drugs Controller India on Contract Basis Susmita Roy24 Feb 2025 10:00 AM ISTNew Delhi: Through a recent notification, the Appointments Committee of the Cabinet has approved the re-employment of Dr. Rajeev Singh Raghuwanshi as...
Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals Ruchika Sharma23 Feb 2025 3:30 PM ISTHyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing...
Morepen Labs arm to form new subsidary Ruchika Sharma23 Feb 2025 1:30 PM ISTHaryana: Morepen Laboratories Limited has announced that the Board of Directors of Dr Morepen Limited, a wholly owned subsidiary of the...
GSK Nucala application for COPD accepted for review in China Ruchika Sharma23 Feb 2025 12:30 PM ISTGSK plc has announced that the China National Medical Products Administration has accepted for review the new drug application for the use of...
Gilead Seladelpar gets Conditional European Marketing Authorization for Primary Biliary Cholangitis Ruchika Sharma23 Feb 2025 11:30 AM ISTFoster City: Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment...
Zydus Chairman says Indian pharma players can deliver 100 new drugs by 2047 Ruchika Sharma22 Feb 2025 5:28 PM ISTThe Indian pharmaceutical industry has the potential to deliver 100 new drugs for global markets by 2047, driven by enhanced research and development...
Zydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis Ruchika Sharma22 Feb 2025 4:26 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug Administration...
Abbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy to step down Ruchika Sharma22 Feb 2025 12:30 PM ISTMumbai: Abbott India has announced that Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her...
